Skip to main content

Published locations for Phase I results move Alzheimer’s candidate drug aducanumab into phase III trials

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase I results move Alzheimer’s candidate drug aducanumab into phase III trials

User login

  • Reset your password
  • /content/phase-i-results-move-alzheimers-candidate-drug-aducanumab-phase-iii-trials
  • /familypracticenews/article/121092/alzheimers-cognition/phase-i-results-move-alzheimers-candidate
  • /internalmedicinenews/article/121092/alzheimers-cognition/phase-i-results-move-alzheimers-candidate
  • /psychiatry/article/121092/alzheimers-cognition/phase-i-results-move-alzheimers-candidate-drug
  • /internalmedicine/article/121092/alzheimers-cognition/phase-i-results-move-alzheimers-candidate-drug
  • /neurology/article/121092/alzheimers-cognition/phase-i-results-move-alzheimers-candidate-drug
  • /familymedicine/article/121092/alzheimers-cognition/phase-i-results-move-alzheimers-candidate-drug
  • /clinicalneurologynews/article/121092/alzheimers-cognition/phase-i-results-move-alzheimers-candidate
  • /clinicalpsychiatrynews/article/121092/alzheimers-cognition/phase-i-results-move-alzheimers-candidate